Ysios Capital (investor - Private Equity)

See something wrong or missing? Let us know
Offices:Barcelona, San Sebastian

Ysios Capital is an independent venture capital firm from Spain that provides private equity financing to early- and mid-stage human healthcare and life science companies and targeting the biotechnology industry, with an exclusive focus on therapeutics.

Average round investment:54.8M USD
Average number per year:2.5
Distribution: 2021 (3)2020 (4)2019 (2)2018 (1)
Mostly invests in: Denmark Denmark (4) Health services (9)
See the entire list

Showing 3 of 9 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Ysios Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ysios Capital

Name Criteria
Singapore Temasek
79%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United Kingdom GP Bullhound
77%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, Spain
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
France Sofinnova Partners
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Kreos Capital
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain, France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Spain Alta Life Sciences | FCR
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Kurma Life Science Partners
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, Spain, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany VSquared Ventures
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Mubadala Capital
76%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
France Supernova Invest
75%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States KKR
74%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Top